课题基金 / 基金详情

Regulation of CD8+ T cell mediated anti-tumor immunity by insulin signalling

Regulation of CD8+ T cell mediated anti-tumor immunity by insulin signalling
通过胰岛素信号调节 CD8 T 细胞介导的抗肿瘤免疫
批准号:
468084
负责人:
Tsai Sue Y
金额:
$4.37万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-02-01 至 2024-02-01

项目摘要

项目成果

Tsai Sue Y的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
During obesity, excessive inflammation can impair the body's responsiveness to insulin, a term called insulin resistance. We discovered that immune cells are responsive to insulin, but can become insulin resistant in obese animals. Since obese individuals
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early Life Determinant of T1D Susceptibility
  • 批准号:
    489506
  • 项目类别:
    Operating Grants
  • 资助金额:
    $76.35万
  • 财政年份:
    2023
  • 负责人:
    Tsai Sue Y
  • 依托单位:
B cell-intrinsic insulin resistance as a mechanism of obesity-linked immune dysfunction
  • 批准号:
    443920
  • 项目类别:
    Operating Grants
  • 资助金额:
    $60.47万
  • 财政年份:
    2021
  • 负责人:
    Tsai Sue Y
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    424857
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2019
  • 负责人:
    Tsai Sue Y
  • 依托单位:
Role of Insulin in T cell Function
  • 批准号:
    362620
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $3.28万
  • 财政年份:
    2016
  • 负责人:
    Tsai Sue Y
  • 依托单位: